VIVS
VIVS
NASDAQ · Biotechnology

Vivosim Labs Inc

$2.28
-0.31 (-11.97%)
As of Feb 8, 2:30 PM ET ·
Analyst Consensus
Strong Sell
7
Analysts
Moderate
Coverage
Buy 0 0%
Hold 4 57%
Sell 3 43%
Price Target
Analyst Price Target +1,155.7% upside
Low Target $25.08
Average Target $28.63
High Target $44.18
Current Price $2.28
Current
$2.28
Target
$28.63
$25.08 $28.63 avg $44.18
Scenario Analysis
Bear Case
$25.08
1,000.0%
Low target
Base Case
$28.63
+1,155.7%
Avg target
Bull Case
$44.18
+1,837.7%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$31.48
-92.8% from high
52-Week Low
$20.65
+-89.0% from low
Target vs 52W High
$28.63
-9.1% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 37 68% $257.58 +15.3%
AMGN
Amgen Inc
Hold 41 54% $190.87 -50.3%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +137.8%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 77% $438.34 -8.3%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.2%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 75% $102.31 -68.8%
INSM
Insmed Inc
Strong Buy 27 93% $143.40 -4.3%
BIIB
Biogen Inc
Hold 42 48% $91.45 -54.5%